跳至主要内容
临床试验/NL-OMON53895
NL-OMON53895招募中不适用

Taste and smell dysfunction in patients more than two years after start of immune checkpoint inhibitor therapy - Taste-SPICIER

niversitair Medisch Centrum Groningen0 个研究点目标入组 0 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patient with melanoma, NSCLC or urogenital cancers >= 2 years since treatment
  • with at least one cycle of immune checkpoint inhibitor (CTLA-4 inhibitor,
  • PD-(L)1 inhibitor, or both) within the Department of Medical Oncology or
  • Pulmonary Oncology of the UMCG.
  • 2. Age >=18 years at time of immune checkpoint inhibitor treatment
  • 3. Understand or abide to the study procedures
  • 4. Have given informed consent
  • A caregiver must meet all of the following criteria:
  • 1. Age >=18 years
  • 2. Understand or abide to the study procedures
  • 3. Have given informed consent

排除标准

  • 1. As previous or subsequent therapies, only surgery and palliative
  • radiotherapy is allowed (excluding radiotherapy in the head-neck and brain
  • 2. Previous treatment in the past ten years for malignancy other than melanoma
  • (excluding non-melanoma skin cancer, cervical intra-epithelial neoplasia (CIN)
  • or carcinoma in situ of breast) (for patients: other than current malignancy)
  • 3. History of ear-nose-throat disease or auto-immune disorder affecting taste,
  • smell, mouth mucosa, or saliva production (for patients: before start ICI)

研究者

相似试验